Form 8.3 ALLIANCE PHARMA PLC

Alliance Pharma

12/05/2025 15:00

RNS Number : 3101I

Barclays PLC

12 May 2025

 

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1.
KEY INFORMATION
(a)
Full name of discloser:
Barclays PLC.
(b)
Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c)
Name of offeror/offeree in relation to whose
ALLIANCE PHARMA PLC
relevant securities this form relates:
(d)
If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e)
Date position held/dealing undertaken:
09 May 2025
(f)
In addition to the company in 1(c) above, is the discloser making
NO
disclosures in respect of any other party to the offer?
2.
POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)
Interests and short positions in the relevant securities of the offeror or offeree
to which the disclosure relates following the dealing(if any)
Class of relevant security:
1p ordinary
Interests
Short Positions
Number
(%)
Number
(%)
(1)
Relevant securities owned
and/or controlled:
5,479,321
1.01%
1,351,096
0.25%
(2)
Cash-settled derivatives:
and/or controlled:
907,087
0.17%
5,479,321
1.01%
(3)
Stock-settled derivatives (including options)
and agreements to purchase/sell:
0
0.00%
0
0.00%
TOTAL:
6,386,408
1.18%
6,830,417
1.26%
(b)
Rights to subscribe for new securities (including directors and other executive
options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3.
DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a)
Purchases and sales
Class of relevant
Purchase/sale
Number of
Price per unit
security
securities
1p ordinary
Purchase
45,440
0.6474 GBP
1p ordinary
Purchase
24,090
0.6460 GBP
1p ordinary
Purchase
10,416
0.6450 GBP
1p ordinary
Purchase
2,227
0.6456 GBP
1p ordinary
Purchase
1,616
0.6480 GBP
1p ordinary
Sale
401
0.6449 GBP
(b)
Cash-settled derivative transactions
Class of
Product
Nature of dealing
Number of
Price per
relevant
description
reference
unit
security
securities
1p ordinary
SWAP
Decreasing Short
401
0.6449 GBP
1p ordinary
SWAP
Increasing Short
4,069
0.6450 GBP
1p ordinary
SWAP
Increasing Short
2,227
0.6456 GBP
1p ordinary
SWAP
Increasing Short
24,090
0.6460 GBP
1p ordinary
CFD
Increasing Short
1,407
0.6450 GBP
(c)
Stock-settled derivative transactions (including options)
(i)
Writing, selling, purchasing or varying
Class
Product
Writing,
Number
Exercise
Type
Expiry
Option
of
description
purchasing,
of
price
date
money
relevant
selling,
securities
per unit
paid/
security
varying etc
to which
received
option
per unit
relates
(ii)
Exercising
Class of relevant
Product description
Exercising/ exercised against
Number of
Exercise price per
security
securities
unit
(d)
Other dealings (including subscribing for new securities)
Class of relevant
Nature of Dealings
Details
Price per unit (if
security
applicable)
4.
OTHER INFORMATION
(a)
Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b)
Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c)
Attachments
Is a Supplemental Form 8 (Open Positions) attached?
NO
Date of disclosure:
12 May 2025
Contact name:
Large Holdings Regulatory Operations
Telephone number:
020 3134 7213


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
RETATMJTMTMBBRA